NetForum uses cookies to ensure that we give you the best experience on our website. If you continue to use the site, we'll assume that you are happy to receive these cookies on the NetForum website. Read about our cookies.
NetForum Community
Learn. Share. Optimize.
Log in | Sign up now | Submit content | Contact
Go to similar content

Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT

Publication
Philips CT Clinical Science Philips Healthcare • USA

Perisinakis K, Seimenis I, Tzedakis A, Karantanas A, Damilakis J.

* This article originally appeared in the October 2018 issue of European Radiology.
Objectives
To estimate (a) organ doses and organ-specific radiation-induced cancer risk from a single low-dose CT (LDCT) for lung cancer screening (LCS) and (b) the theoretical cumulative risk of radiation-induced cancer for a typical cohort to be subjected to repeated annual LCS LDCT.

Methods
Sex- and body size-specific organ dose data from scan projection radiography (SPR) and helical CT exposures involved in LCS 256-slice LDCT were determined using Monte Carlo methods. Theoretical life attributable risk (LAR) of radiogenic cancer from a single 256-slice chest LDCT at age 55-80 years and the cumulative LAR of cancer from repeated annual LDCT studies up to age 80 years were estimated and compared to corresponding nominal lifetime intrinsic risks (LIRs) of being diagnosed with cancer.

Results
The effective dose from LCS 256-slice LDCT was estimated to be 0.71 mSv. SPR was found to contribute 6-12% to the total effective dose from chest LDCT. The radiation-cancer LAR from a single LDCT study was found to increase the nominal LIR of cancer in average-size 55-year-old males and females by 0.008% and 0.018%, respectively. Cumulative radiogenic risk of cancer from repeated annual scans from the age of 55-80 years was found to increase the nominal LIR of cancer by 0.13% in males and 0.30% in females.

Conclusion
Modern scanners may offer sub-millisievert LCS LDCT. Cumulative radiation risk from repeated annual 256-slice LDCT LCS examinations was found to minimally aggravate the lifetime intrinsic cancer risk of a typical screening population.

Key Points
  • Effective dose from lung cancer screening low-dose CT may be <1 mSv.
  • Screening with modern low-dose CT minimally aggravates lifetime cancer induction intrinsic risk.
  • Dosimetry of lung cancer screening low-dose CT should encounter the radiation burden from the localizing scan projection radiography.
  • DLP method may underestimate effective dose from low-dose chest CT by 27%.
For more information about this publication, check out the PubMed listing for this article.


This content has been made possible by NetForum Community.
Share this on: Share your link in twitter Share your link in facebook Share your link on LinkedIn Print Rate this article: Log in to vote

 
Rating:
Votes:
0
Views:
39
Added:
Oct 9, 2018

Rate this:
Log in to vote
 

Publication
iCT
Body, chest, dose, low dose, lung cancer, lungs, Oncology, screening
 

Clinical News
Best Practices
Case Studies
Publications and Abstracts
White Papers
Web seminars and Presentations
ExamCards
Protocols
Application Tips and FAQ
Training
Try an Application
Business News
Case Studies
White Papers
Web Seminars and Presentations
Utilization Services
Contributing Professionals
Contributing Institutions
Become a Contributor